In a new advertisement that's turning heads in the fitness world, actor Hudson Williams, known for his role in the steamy hockey romance Heated Rivalry, showcases a variety of workouts on Peloton equipment. The commercial, featuring Williams sweating through runs on a $6,695 Tread Plus treadmill, dumbbell squats, planking, and shadow boxing alongside popular instructor Tunde Oyeneyin, is set to David Bowie's 'Fame.' Notably absent from the spot is the iconic Peloton Bike, and the setting shifts from the typical upscale home gym to a spacious professional facility.
This latest marketing push comes amid Peloton's ongoing efforts to redefine its identity under new leadership. Peter Stern, who took over as CEO in early 2024 after serving as a Ford executive and cofounder of Apple Fitness+, has emphasized expanding the company's scope beyond traditional cardio equipment. In recent earnings calls, Stern has described Peloton not as a fitness company, but as a 'wellness company,' focusing on areas like 'strength, stress management, sleep, and nutrition,' according to reports from The Verge.
The commercial's themes align closely with Stern's strategic vision. A Bloomberg report highlighted in industry analysis suggests Peloton plans to leverage its new AI feature, dubbed Peloton IQ, for more personalized workout plans using data from wearables. The company is reportedly eyeing partnerships with gyms and lifestyle brands to extend its reach beyond the home, while prioritizing treadmills over bikes in future growth. Stern's initiatives also include a hardware refresh with increased subscription fees and the integration of AI tools, though these changes have coincided with two rounds of layoffs at the company this year.
Peloton's history is marked by dramatic shifts, often reflected in its advertising. Four years ago, under then-CEO Barry McCarthy, the company pivoted toward subscription services with an ad featuring a buff Christopher Meloni promoting the Peloton app—while working out in the buff. That era contrasted with the 2019 holiday commercial, which drew backlash for depicting a husband gifting his wife a Peloton bike, reinforcing perceptions of the brand as a luxury item for affluent, tech-savvy consumers in idealized suburban settings.
The COVID-19 pandemic propelled Peloton into the spotlight, with demand skyrocketing as home workouts became essential. However, the boom was followed by challenges, including product recalls, business missteps, and high-profile media moments like the death of Mr. Big—portrayed by Chris Noth—on a Peloton bike in the 2021 premiere of And Just Like That.... In response, Peloton aired a follow-up ad with Noth himself, which quickly backfired when sexual harassment allegations surfaced against the actor weeks later. Shortly after, founder and then-CEO John Foley stepped down in December 2021.
These events underscore Peloton's volatile trajectory. From 2020 to 2023, the company faced near-constant scrutiny, with frequent debacles ranging from safety issues to questionable product placements. Veteran observers note that while the core product—a connected exercise bike with live and on-demand classes—remains popular, the company's ambitions to diversify have often led to setbacks.
Recent product testing provides insight into Peloton's current offerings. The updated Bike Plus, part of the new Cross Training series, includes enhancements like a cushier seat, an improved phone stand, a built-in fan, and a camera for strength training sessions that sometimes accurately counts reps. Peloton IQ allows users to generate AI-driven strength programs quickly, and a new workout indicator rates difficulty relative to a user's typical sessions—'harder, the same, or easier.'
However, not all feedback is glowing. Victoria Song, a senior reviewer at The Verge, shared her three-month experience testing the Bike Plus, noting persistent issues like discomfort from the seat during longer rides and instructors' unrelentingly high energy. While appreciating some AI conveniences, Song expressed skepticism about the platform's ability to deliver truly personalized plans, especially for users with complex health needs.
Song, who has been prescribed GLP-1 medications as part of treatment for metabolic dysfunction-associated steatotic liver disease, highlighted the booming market for such drugs and Peloton's reported interest in targeting these users. 'Strength training is hugely important for GLP-1 users, as the prolonged appetite suppression can contribute to muscle loss,' she wrote. Marketing home-based strength options could appeal to those intimidated by gyms, but Song questioned the efficacy of AI and wearable integrations for genuine customization.
In her analysis, Song described current AI features across fitness platforms as underwhelming. 'AI coaching? Terrible for accountability because they’re so easily bullied. AI nutrition features? Can’t tell when I’ve made healthy swaps, and they make logging so tedious I’d rather just not eat,' she stated. Peloton's existing AI-generated strength plans, while easy to create, often require significant modifications to suit individual limitations, leading users to prefer self-designed programs or instructor-led classes.
Song envisioned a more sophisticated system where users could input detailed health data—such as medication side effects, fitness history, wearable metrics, and goals like returning to 5K runs after half-marathon training—and receive a tailored, adaptable four-week plan. Attempts with various AI tools, including Whoop's, have yielded only basic suggestions, she reported, falling short of sustainable, realistic guidance for conditions involving nausea, dehydration, or disrupted sleep.
Despite these critiques, Song acknowledged benefits from Peloton's core strengths. During her testing, the platform's value lay in its classes and instructor motivation, accessible privately at home. This echoes sentiments from a dozen loyal fans interviewed for Song's 2024 in-depth report on Peloton's business, who cited the emotional connection to instructors as a key draw.
Peloton's exploration of gym partnerships and treadmill focus aims to attract new users, as treadmills represent a faster-growing segment than bikes. Yet, the company's past successes, Song argued, stemmed from embracing its fitness roots rather than chasing broader wellness trends. 'Pressures to be bigger, grow faster, and do more seem to continually blow up in its face,' she observed, questioning whether Peloton should simply remain 'just' a fitness company.
Looking ahead, the impact of Stern's pivot remains uncertain. With Peloton IQ poised to expand into sleep, nutrition, and stress management—potentially incorporating more wearable data—the platform could broaden its appeal, especially to the growing GLP-1 user base. However, industry watchers caution that overextending from its hardware-subscription model risks diluting the brand's loyal following. As Peloton navigates this latest chapter, its ability to balance innovation with its foundational appeal will likely determine its long-term viability in a crowded wellness market.
The Appleton Times reached out to Peloton for comment on the new commercial and strategic direction but did not receive an immediate response. Analysts continue to monitor quarterly earnings for signs of stabilization, following years of turbulence that have tested the endurance of both the company and its enthusiasts.